Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyang Yao

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|October 3, 2017
The Science Behind the Academy for Eating Disorders' Nine Truths About Eating DisordersKatherine Schaumberg, Elisabeth Welch, Lauren Breithaupt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Transcriptomic and genetic analysis suggests a role for mitochondrial dysregulation in schizophreniaLisa Bast, Shuyang Yao, José A Martínez-López, et al.
Nature Cardiovascular Research|August 30, 2024
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Distinct genomic signatures and modifiable risk factors underly the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Nature Cardiovascular Research|June 20, 2024
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Science (New York, N.Y.)|April 27, 2023
Leveraging base-pair mammalian constraint to understand genetic variation and human diseasePatrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Leveraging Base Pair Mammalian Constraint to Understand Genetic Variation and Human DiseasePatrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2025
Integrating GWAS meta-analysis with human brain cell mapping implicates the amygdala and the midbrain in the pathogenesis of tinnitusNick M A Shubert, Shuyang Yao, Maryam Kazemi Naeini, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|October 3, 2017
The Science Behind the Academy for Eating Disorders' Nine Truths About Eating DisordersKatherine Schaumberg, Elisabeth Welch, Lauren Breithaupt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Transcriptomic and genetic analysis suggests a role for mitochondrial dysregulation in schizophreniaLisa Bast, Shuyang Yao, José A Martínez-López, et al.
Nature Cardiovascular Research|August 30, 2024
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Distinct genomic signatures and modifiable risk factors underly the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Nature Cardiovascular Research|June 20, 2024
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular diseaseJacob Bergstedt, Joëlle A Pasman, Ziyan Ma, et al.
Science (New York, N.Y.)|April 27, 2023
Leveraging base-pair mammalian constraint to understand genetic variation and human diseasePatrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Leveraging Base Pair Mammalian Constraint to Understand Genetic Variation and Human DiseasePatrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2025
Integrating GWAS meta-analysis with human brain cell mapping implicates the amygdala and the midbrain in the pathogenesis of tinnitusNick M A Shubert, Shuyang Yao, Maryam Kazemi Naeini, et al.
Pageof 6